Category: Cannabis News
The US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) to VER-01, the flagship full-spectrum cannabis drug from Munich-based Vertanical, putting it in prime position to become the first FDA-approved cannabis-derived medicine for pain, and only the second such approval since Epidiolex in 2018. VER-01’s FDA designation, granted on 18 May 2026, […]
Cannabis Europa London is back at The Barbican Centre for two days of conversations with global cannabis leaders, policymakers, industry analysts and patient representatives, and, as ever, the sun has shown up. ‘Cannabis Europa is always blessed with great weather,’ Stephen Murphy, Co-Founder and CEO of Prohibition Partners, told delegates as he opened proceedings. As […]
Cannabis Europa London returns on 26-27 May 2026, bringing together operators, investors, clinicians, and policymakers from across the global cannabis industry for two days of main-stage debate, exhibition, and networking. This article is part of a series published by Business of Cannabis ahead of the event, drawing on the perspectives of Cannabis Europa’s leading sponsors and speakers, the […]
Adriano Fernandes, Head of Growth and Business Development at leading cultivator CANNA – a Cannabis Europa VIP Partner – shares his thoughts on the industry’s trajectory As we head into Cannabis Europa, what do you see as the most significant developments shaping the European cannabis industry right now, and where does CANNA sit within that […]
Canadian producers shipped 17,067kg of medical cannabis directly to the UK in 2025, more than six times the 2,578kg recorded the year before, according to the latest official Home Office data seen by Business of Cannabis. It comes as the total amount of cannabis flower being imported into the UK more than doubled in 2025 […]
As the European cannabis conference season gets started, industry experts, lawmakers, regulators and business owners are facing greater mainstream scrutiny than ever before. From police raids in Portugal and North Macedonia, to a media backlash in the UK, operators are facing increasing questions about the industry’s resilience in the face of coordinated pushback. Europe’s largest […]
More than 70 international speakers and over 1000 delegates set to convene on London next month for policy debates, high-level networking and the 2026 Business of Cannabis Awards Cannabis Europa, the leading B2B conference for the European cannabis industry, today announced the full programme for its 2026 London edition. Taking place at The Barbican on […]
As the European medical cannabis market has developed, expanded and matured over the last half-decade, Portugal has played a critical role in the global supply chain, earning a reputation as the ‘doorway to Europe’. Dried flower from Canada, Colombia, Thailand and a swathe of other global exporters has been diverted through the Portuguese processing hub […]
Germany’s imports for 2025 surpassed 200 tonnes for the first time, exceeding the country’s already revised import quota for the second time in a year. The latest medical cannabis import figures from BfArM, covering the final quarter of 2025, show that the post-CanG boom may finally be slowing after consecutive periods of high double-digit growth. […]
Last month, the German cannabis market saw its most significant consolidation deal to date, as Canadian heavyweight Organigram announced plans to acquire Sanity Group in a deal worth up to €250m. Given its size, especially compared to the relatively modest acquisition of Remexian late last year, it’s no surprise Sanity’s deal has captured the market’s […]